BRAF and targeted treatment for non-small cell lung cancer

VernacularTitle:BRAF基因与非小细胞肺癌的分子靶向治疗
Author: Xiaoyan KANG ; Liyan QU ; Xia SONG
Publication Type:Journal Article
Keywords: Carcinoma,non-small-cell lung; Therapy; BRAF gene
From: Journal of International Oncology 2016;43(8):625-627
CountryChina
Language:Chinese
Abstract: B-Raf kinase (BRAF) gene is a driver mutation,and is an effective target in the treatment of non-small cell lung cancer (NSCLC).Studies have shown that BRAF inhibitors are effective for treatment of NSCLC with BRAF mutant.It is important to understand the clinicopathologic features and the research progress of BRAF inhibitors for the individual treatment of NSCLC.